摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(benzo[b]thiophen-2-yl)-2-hydroxyacetic acid | 18021-48-2

中文名称
——
中文别名
——
英文名称
2-(benzo[b]thiophen-2-yl)-2-hydroxyacetic acid
英文别名
benzo[b]thiophen-2-ylhydroxyacetic acid;2-(2-Benzothienyl)-2-hydroxyacetic Acid;2-(1-benzothiophen-2-yl)-2-hydroxyacetic acid
2-(benzo[b]thiophen-2-yl)-2-hydroxyacetic acid化学式
CAS
18021-48-2
化学式
C10H8O3S
mdl
——
分子量
208.238
InChiKey
YOXZBBZJNJBYIT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    437.5±30.0 °C(Predicted)
  • 密度:
    1.501±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    85.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(benzo[b]thiophen-2-yl)-2-hydroxyacetic acid氯化亚砜 作用下, 以 异丙醚 为溶剂, 反应 6.5h, 生成 ethyl (S)-2-acetoxy-2-(benzo[b]thiophen-2-yl)acetate
    参考文献:
    名称:
    Sequential enzymatic procedure for the preparation of enantiomerically pure 2-heteroaryl-2-hydroxyacetic acids
    摘要:
    Starting from the racemic 2-benzofuranyl- and 2-benzo[b]thiophenyl-2-hydroxyacetic acid ethyl esters as substrates, a general method was developed for the efficient synthesis of the corresponding highly enantiomerically enriched (ee up to 99%) (R)- and (S)-2-heteroaryl-2-hydroxyacetic acids. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2012.01.019
  • 作为产物:
    描述:
    1-苯并噻酚-2-羧醛盐酸 、 zinc(II) iodide 作用下, 以 1,4-二氧六环甲醇二氯甲烷 为溶剂, 反应 24.0h, 生成 2-(benzo[b]thiophen-2-yl)-2-hydroxyacetic acid
    参考文献:
    名称:
    Sequential enzymatic procedure for the preparation of enantiomerically pure 2-heteroaryl-2-hydroxyacetic acids
    摘要:
    Starting from the racemic 2-benzofuranyl- and 2-benzo[b]thiophenyl-2-hydroxyacetic acid ethyl esters as substrates, a general method was developed for the efficient synthesis of the corresponding highly enantiomerically enriched (ee up to 99%) (R)- and (S)-2-heteroaryl-2-hydroxyacetic acids. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2012.01.019
点击查看最新优质反应信息

文献信息

  • [EN] PESTICIDAL COMPOUNDS<br/>[FR] COMPOSÉS PESTICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2016012333A1
    公开(公告)日:2016-01-28
    A method of combating and controlling insects, acarines, nematodes or molluscs which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I), wherein R1 is R4, YR5 or ZR6; Y is CO or C=S; Z is S, S(O), SO2 or PO2; and A is an optionally substituted phenyl or an optionally substituted heteroaromatic ring, wherein R1 to R6 are defined organic groups; new compounds are also provided.
    一种用于对抗和控制昆虫、螨虫、线虫或软体动物的方法,包括向害虫、害虫栖息地或易受害虫攻击的植物施加化学式(I)中的一种化合物的杀虫、杀螨、杀线虫或杀软体动物有效量,其中R1为R4、YR5或ZR6;Y为CO或C=S;Z为S、S(O)、SO2或PO2;A为一个可选择取代的苯基或可选择取代的杂环,其中R1至R6为定义的有机基团;还提供了新的化合物。
  • PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS
    申请人:Cutshall Neil S.
    公开号:US20100035872A1
    公开(公告)日:2010-02-11
    Compounds that inhibit PDE10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety, movement disorders and/or neurological disorders such as Parkinson's disease, Huntington's disease, Alzheimer's disease, encephalitis, phobias, epilepsy, aphasia, Bell's palsy, cerebral palsy, sleep disorders, pain, Tourette's syndrome, schizophrenia, delusional disorders, drug-induced psychosis and panic and obsessive-compulsive disorders. Pharmaceutically acceptable salts, stereoisomers, solvates and prodrugs of the compounds are also provided. Also disclosed are compositions containing a compound in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting PDE10 in a warm-blooded animal in need of the same.
    揭示了抑制PDE10的化合物,可用于治疗多种疾病,包括(但不限于)精神病、焦虑、运动障碍和/或神经系统疾病,如帕金森病、亨廷顿病、阿尔茨海默病、脑炎、恐惧症、癫痫、失语症、贝尔氏面瘫、脑性瘫痪、睡眠障碍、疼痛、抽动症、精神分裂症、妄想症、药物诱导的精神病和惊恐症以及强迫症。此外,还提供了这些化合物的药用盐、立体异构体、溶剂合物和前药。还揭示了含有化合物的组合物,与药用载体结合,以及与使用这些组合物抑制温血动物中的PDE10相关的方法。
  • US4492693A
    申请人:——
    公开号:US4492693A
    公开(公告)日:1985-01-08
  • US8377930B2
    申请人:——
    公开号:US8377930B2
    公开(公告)日:2013-02-19
  • US9783521B2
    申请人:——
    公开号:US9783521B2
    公开(公告)日:2017-10-10
查看更多

同类化合物